Navigation Links
LX211 highlighted as potential disease modifying therapy for non-infectious uveitis
Date:10/26/2009

ltimately to improved outcomes in this difficult-to-treat condition."

Results of the LX211-01 study, which investigated LX211 in 218 patients with active, sight-threatening uveitis affecting the posterior segment of the eye, will also be presented at AAO on Monday October 26 at 9:00 am PT by clinical investigator Quan D. Nguyen, M.D., of the Wilmer Eye Institute at The Johns Hopkins University, Baltimore, MD. "In this study, also a double-masked, placebo-controlled, dose-ranging trial conducted in North America, Europe and India, control of inflammation was evaluated by means of change in vitreous haze at weeks 16 and 24. Results showed the LX211 presumed label dose of 0.4 mg/kg twice daily to be statistically significantly superior to placebo at both time points. Preservation of vision was also demonstrated in this study."

In explaining the overall clinical benefit, C. Stephen Foster, MD, President, Massachusetts Eye Research and Surgery Institution (MERSI), highlighted the ability of LX211 to control inflammation and to significantly delay recurrence of inflammatory exacerbation compared to the control group. Moreover, this result was achieved while successfully reducing corticosteroids to 5 mg/day or less. "Therapy with LUVENIQ conforms to the 2000 uveitis treatment guidelines, and is supported by randomized clinical trials that offer the highest level of evidence-based support. Once approved, LUVENIQ would be the only uveitis therapy so rated and thus, one that should always be offered," Dr. Foster stated in his presentation to the AUS on Sunday October 25 at 8:00 pm PT.

Treatment with LX211 was overall well tolerated at the twice-daily 0.4 mg/kg dose, demonstrating a safety profile that appears suitable for chronic use. Adverse effects on renal function (8.2% of subjects with decrease from baseline of ≥30% in glomerular filtration rate vs. 4.1 % in placebo) and blood pressure (mean increase in systolic BP by 6 mm Hg) were moder
'/>"/>

Contact: Joan Kureczka
JKureczka@comcast.net
415-821-2413
Kureczka/Martin Associates
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Peregrines PS-targeting antibodies highlighted in AACR Annual Meeting studies
2. Agricultural research highlighted in Houston
3. Heat forms potentially harmful substance in high-fructose corn syrup
4. Iowa State University researcher uncovers potential key to curing tuberculosis
5. Mechanism for potential Friedreichs ataxia drug uncovered
6. The vasculature emerges as a potential therapeutic target in treating ADPKD liver cysts
7. National new biology initiative offers potential for remarkable and far-reaching benefits
8. Fear of insurance rejection deters potentially life saving genetic tests for bowel cancer
9. Time to tap climate change-combating potential of the worlds ecosystems
10. Time to tap climate-change-combating potential of the worlds ecosystems
11. UCSB scientists discover potential drug delivery system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... the world are meeting next week in Toronto. ... the latest in research findings about the brain, ... the disorders that affect them., "Canada is a ... showcase the best of neuroscience research done here ... of the Canadian Association for Neuroscience. He also ...
(Date:5/16/2013)... May 16, 2013 Reportlinker.com announces ... available in its catalogue: ... 2018 http://www.reportlinker.com/p01181929/Global-Biometric-Systems-Market-Forecast--Opportunities-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Security_Systems ... security practises such as photographs, passwords and ... biometric technologies in last few years. Security ...
(Date:5/15/2013)... "keystone" molecules that have powerful behavioral effects on ... in structuring ecosystems, according to a theory proposed ... The authors of the theory, Ryan P. Ferrer ... of the University of California at Los Angeles, ... plants that may be uncommon but exert a ...
Breaking Biology News(10 mins):7th Annual Canadian Neuroscience Meeting, Toronto, May 20-24, 2013 2Global Biometric Systems Market Forecast & Opportunities, 2018 2Global Biometric Systems Market Forecast & Opportunities, 2018 3Global Biometric Systems Market Forecast & Opportunities, 2018 4Global Biometric Systems Market Forecast & Opportunities, 2018 5Global Biometric Systems Market Forecast & Opportunities, 2018 6Global Biometric Systems Market Forecast & Opportunities, 2018 7Natural 'keystone molecules' punch over their weight in ecosystems 2
... research study led by scientists at Scripps Institution of ... overall ocean health, corals are better able to recover ... force corals to expel their symbiotic algae, known as ... to increase in frequency as global climate change increases ...
... members of the University of Minnesota,s BioTechnology Institute, developed ... MaxDiscovery Melamine Test kit, which simplifies the detection of ... that killed six Chinese children and hospitalized 150,000 last ... its apparent protein content. Some children may have life-long ...
... - In the July issue of Biomaterials , ... Florida (UCF) report on the first lab-grown motor nerves ... in the human body. The model system will ... such as diabetic neuropathy and later, possibly multiple sclerosis ...
Cached Biology News:Scripps-led study shows ocean health plays vital role in coral reef recovery 2University of Minnesota research leads to new technology to protect human health 2Researchers design first model motor nerve system that's insulated and organized like the human body 2
(Date:5/16/2013)... Cambridge Healthtech Institute will host its fifth ... the Renaissance Waterfront Hotel in Boston, MA. The ... at the current strategies and innovations for optimizing bioprocesses ... in the field will reveal how their work has ... specificity and efficiency. , “In this age of rapid ...
(Date:5/16/2013)... , May 16, 2013  The registration deadline ... Bioscience Financial Officers (ABFO) 2013 National Conference, the premier ... held May 28-31 at the Hilton San Diego Bayfront. ... on this year,s conference and want to make sure ... attend," said Brandi Roberts , Chief ...
(Date:5/16/2013)... 16, 2013 On average, developing a ... one billion dollars. Despite this investment, less than 10% ... high, is your clinical trial design optimally structured to ... outcomes? , Dr. Frederic Sax, Global Head of the ... use of data, information and technology in upfront clinical ...
(Date:5/16/2013)... BioInformatics LLC New Market Report – ... Cells: Current and Future Opportunities (13-004) , With ... the primary cells market continues to increase. In this ... most often, how satisfied scientists are with commercially available ... growth rate. ,  , Additionally, terminally differentiated cells ...
Breaking Biology Technology:The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 2BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 3
... 2009, Platoon Fitness is holding Platoon University at Bryn Mawr Outdoor ... , BRYN MAWR, Pa., June 5 Platoon Fitness is ... certifying trainers from around the country in its outdoor training methods. ... exciting new techniques in the realm of outdoor fitness. Over 1100 ...
... FRANCISCO, Calif., June 5 Poniard Pharmaceuticals, Inc. (Nasdaq: ... innovative oncology therapies, today announced that Jerry McMahon, Ph.D., ... overview at the 8th Annual Needham Life Sciences Conference ... in New York. , , Dr. ...
... 5 Dendreon Corporation (Nasdaq: DNDN ) today announced that ... , Goldman Sachs 30th Annual Global Healthcare Conference, ... 8th Annual Needham Life Sciences Conference, ... The presentations will be audio webcast live and available for replay ...
Cached Biology Technology:Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference 2